The Diary Of A CEO

HAVE DOCTORS BEEN IGNORING THE DATA?

Every hour, 70 people die from cancer in the United States. That’s roughly 1,700 lives every day. When I read those stats, I realised how overwhelming it can feel to try understand this disease and why it can feel almost impossible to navigate the science behind it. That is why I invited Professor Thomas Seyfried back to try and understand the science further, question the system and explore what we may still be getting wrong. Thomas has spent 50 years researching cancer. He is a Professor of Biology at Boston College, the author of more than 150 peer-reviewed papers and one of the most passionate people I have met when speaking about this disease. His work explores a metabolic view of cancer. In simpler terms, he believes we need to pay much closer attention to how cancer cells create energy, how their metabolism differs from healthy cells and what that could mean for future research. We discussed things like: - The new research he brought into the studio in a confidential envelope… - How damaged mitochondria could change the way we understand cancer. - The three things he believes matter most for living longer. - Why cutting sugar alone does not fully explain how cancer cells survive. - Where keto can become dangerous or misunderstood?! - Changes he would make if he were responsible for public health. There were moments when I asked Thomas to simplify his explanations and pushed for greater clarity about what has been demonstrated in research and what still needs further study. That distinction matters. Thomas’s work is focused on scientific research rather than clinical practice. In this conversation, we examine the evidence behind his ideas, what has been studied so far and which questions still require further research. I left this conversation thinking about how progress often begins - someone asks a question that does not fit comfortably inside the existing explanation, then spends decades trying to answer it. Cancer will affect almost every family in some way. So this is of course a challenging conversation, but it is one I believe is worth hearing in full. For anyone who wants to understand a debated perspective in modern cancer research and examine the evidence behind it, I recommend watching this conversation. *The views expressed are those of the guest and this conversation is intended for general informational purposes only. This podcast and its associated materials should not be used as a substitute for professional medical advice, diagnosis, or treatment.